Prolonged Release Period of Nitric Oxide Gas for Treatment of Bacterial Keratitis by Amine-Rich Polymer Decoration of Nanoparticles
Source abstract
Abstract
Exogeneous nitric oxide (NO) delivery is a promising therapeutic method because NO is a significant cell signaling molecule to control physiological functions. A major challenge for NO delivery is to control release due to the fast diffusion properties of gaseous molecules with low molecular weight. It is important in biomedical applications to mitigate initial burst emissions because higher concentrations of reactive NO cause cytotoxicity and tissue damage. In this study, a nanoparticle system is developed to control spontaneous gas release on the basis of surface-modified silica nanoparticles (Si NPs) by branched polyethylene imine (BPEI). BPEI is not only a scaffold of N-diazeniumdiolates—a type of NO donor—and but also a stabilizer of donors by molecular interactions with nearby amine groups. With the sustained-release manner, BPEI-coated NO-releasing Si NPs (BPEI-NO NPs) have multifunctional properties, including bactericidal efficacies as well as good cell viability for human cells. An improved ocular wound recovery is achieved in the mouse keratitis model. This study demonstrates the great potential of the NO-releasing NP as a multifunctional nanotherapeutic in biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Perovskite Materials and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, Yonsei University, Seoul 03722, Republic of Korea
Department of Ophthalmology, Dongguk University, Ilsan Hospital, Goyang 10326, Republic of Korea
Department of Chemistry, Kwangwoon University, Seoul 01897, Republic of Korea
Biotechnology Research Center, JCBIO Co., LTD & Avison Biomedical Research Center (ABMRC), Yonsei University, Seoul 03722, Republic of Korea
Funding
Korea Health Industry Development Institute · National Research Foundation of Korea
References (56)
Show source-provided references
1. 10.1006/niox.1997.011810.1006/niox.1997.0118 ↗
2. 10.1039/C3TB21259A10.1039/C3TB21259A ↗
3. 10.1021/cr000040l10.1021/cr000040l ↗
4. 10.1021/ja029153810.1021/ja0291538 ↗
5. 10.1021/ja067433810.1021/ja0674338 ↗
6. 10.1021/ja01469a01210.1021/ja01469a012 ↗
7. 10.1016/1058-6741(92)90045-Y10.1016/1058-6741(92)90045-Y ↗
8. 10.1002/adhm.20160015010.1002/adhm.201600150 ↗
9. 10.1021/acsbiomaterials.7b0025510.1021/acsbiomaterials.7b00255 ↗
10. 10.1021/acsbiomaterials.7b0003910.1021/acsbiomaterials.7b00039 ↗
11. 10.1002/adma.20160493210.1002/adma.201604932 ↗
12. 10.1016/j.niox.2008.04.00310.1016/j.niox.2008.04.003 ↗
13. 10.1038/jid.2009.9510.1038/jid.2009.95 ↗
14. 10.1016/j.freeradbiomed.2010.04.03410.1016/j.freeradbiomed.2010.04.034 ↗
15. 10.1016/j.ajpath.2011.12.01310.1016/j.ajpath.2011.12.013 ↗
16. 10.1021/ja029153810.1021/ja0291538 ↗
17. 10.1021/ja067433810.1021/ja0674338 ↗
18. 10.1021/cm702526q10.1021/cm702526q ↗
19. 10.1021/acsami.5b1094210.1021/acsami.5b10942 ↗
20. 10.1039/c2cs15272j10.1039/c2cs15272j ↗
21. 10.1002/adfm.20110170710.1002/adfm.201101707 ↗
22. 10.1038/s41598-017-10169-510.1038/s41598-017-10169-5 ↗
23. 10.1039/C4NR07373H10.1039/C4NR07373H ↗
24. 10.1021/acsami.5b0761310.1021/acsami.5b07613 ↗
25. 10.1021/acs.molpharmaceut.7b0037110.1021/acs.molpharmaceut.7b00371 ↗
26. 10.1167/iovs.08-310710.1167/iovs.08-3107 ↗
27. 10.1186/s12886-017-0604-210.1186/s12886-017-0604-2 ↗
28. 10.1167/iovs.16-2060310.1167/iovs.16-20603 ↗
29. 10.1021/ja01486a02110.1021/ja01486a021 ↗
30. 10.1007/s11051-010-9910-910.1007/s11051-010-9910-9 ↗
31. 10.1021/jo00058a03010.1021/jo00058a030 ↗
32. 10.1021/nn700191f10.1021/nn700191f ↗
33. 10.1039/b901671f10.1039/b901671f ↗
34. 10.1021/bm060361s10.1021/bm060361s ↗
35. 10.1039/c2jm15129d10.1039/c2jm15129d ↗
36. 10.1021/ja00322a00410.1021/ja00322a004 ↗
37. 10.1039/C0EE00330A10.1039/C0EE00330A ↗
38. 10.1016/j.apsusc.2015.06.05710.1016/j.apsusc.2015.06.057 ↗
39. Naumkin, A. V.; Kraut-Vass, A.; Gaarenstroom, S. W.; Powell, C. J. http://srdata.nist.gov/xps/Default.aspx, accessed Sep 2012.
40. 10.1016/j.biomaterials.2012.03.00410.1016/j.biomaterials.2012.03.004 ↗
41. 10.1172/JCI11947310.1172/JCI119473 ↗
42. 10.1038/nrmicro100410.1038/nrmicro1004 ↗
43. 10.1080/1521654070131114710.1080/15216540701311147 ↗
44. 10.1074/jbc.M50704220010.1074/jbc.M507042200 ↗
45. 10.2174/092986651060201000110.2174/0929866510602010001 ↗
46. 10.3389/fimmu.2012.0019510.3389/fimmu.2012.00195 ↗
47. 10.1080/0927394059095101610.1080/09273940590951016 ↗
48. 10.1016/S0736-0266(02)00141-910.1016/S0736-0266(02)00141-9 ↗
49. 10.1002/(SICI)1097-4652(199602)166:2<413::AID-JCP20>3.0.CO;2-A10.1002/(SICI)1097-4652(199602)166:2<413::AID-JCP20>3.0.CO;2-A ↗
50. 10.1021/cr000040l10.1021/cr000040l ↗
51. 10.1021/ic800027m10.1021/ic800027m ↗
52. 10.1021/ja029153810.1021/ja0291538 ↗
53. 10.1021/ja01482a00810.1021/ja01482a008 ↗
54. 10.1021/ol902282y10.1021/ol902282y ↗
55. 10.1021/ed079p142710.1021/ed079p1427 ↗
56. 10.1002/jps.260065123010.1002/jps.2600651230 ↗